Download FREE Report Sample
Download Free sampleThe global Automated Breast Ultrasound Systems (ABUS) market was valued at 513.89 Million USD in 2021 and will grow with a CAGR of 17.22% from 2021 to 2027, based on Research newly published report.
The prime objective of Automated Breast Ultrasound Systems Market is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, Automated Breast Ultrasound Systems Market covers market segmentation by major market vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
ABUS is a comfortable, non-ionizing alternative to other supplemental screening options for women with dense breast tissue.Approximately 40% of American women have dense breasts.Having dense breasts can increase a woman`s risk to develop cancer by 4-6 times.Mammography may miss cancers in dense breasts, Invenia ABUS has been proven to find 55% more invasive cancers after a normal or benign mammographic finding.
By Market Vendors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy